RECENT NEWS
New test for the detection of synovial sarcoma
ProPath has announced the addition of SS18-SSX to its antibody library. It is a fusion-specific antibody that is highly sensitive (95%) and specific (100%) for the detection of synovial sarcoma.
Method comparisons: an article series
In the third article in his series on method comparisons, now published in the December issue, Stephen MacDonald focuses on what differences are expected and acceptable, and what other factors need further investigation.
Thank you, and best wishes for Xmas and 2021
The team responsible for publication of Pathology in Practice wishes to acknowledge the support received in difficult times over the past months from readers, contributors and commercial colleagues.
Surveillance of AMR diseases could be more challenging outside the EU
In a new report from the Microbiology Society, experts from around the UK explain the desperate need for long-term and ambitious funding for surveillance and research into antimicrobial resistance (AMR).
Biomedical Science Industry Handbook: reflecting on IVD expertise
The Biomedical Science Industry Handbook 2021 is now available as a hard copy and in digital format. It provides comprehensive information on the full range of products and services from the in vitro diagnostics (IVD) industry.
Rare genetic mutation: a driver of multiple tumour malignancies
Hummingbird Bioscience, a clinical-stage biotechnology company focused on developing revolutionary therapies for hard-to-drug targets, has announced a collaboration with Tempus, a leader in artificial intelligence (AI) and precision medicine.
An improved qPCR pipetting experience
Integra Biosciences’ VIAFLO electronic pipettes are making qPCR plate preparation the straightforward process it should be for researchers in the Saint-Geniez laboratory at Harvard Medical School.
Next-generation digital data management solution
As part of Olympus' commitment to providing digital solutions that improve the efficiency of cancer and stem cell research, the Olympus Provi CM20 incubation monitoring system has changed the way cell culture monitoring is conducted.
Effectiveness of new tools for standardising ER testing confirmed
Boston Cell Standards will present the results of a Canadian study that tested the first system of reference materials for standardisation of oestrogen receptor (ER) testing for breast cancer at the virtual San Antonio Breast Cancer Symposium.
Surgical site infection: a time to act
Urgent action is required to reduce the devastating impact of surgical site infections (SSIs) in the UK, according to the report entitled ‘Time to Act: A State of the Nation Report on Surgical Site Infections in the UK’.
Delivering streamlined and automated software testing services
CliniSys Group has formed a partnership with Software Testing Solutions (STS) that will support CliniSys’ delivery of automated software testing services for its WinPath Enterprise LIMS and ICE solutions.
Method comparison studies: a look at acceptability criteria
In the third article in his series on method comparisons, Stephen MacDonald focuses on what differences are expected and acceptable, and what other factors need further investigation. Read the full feature in the December issue.
Rapid triaging of patients during COVID-19: December cover article
Triaging patients presenting with acute respiratory infection symptoms in the influenza season can be a minefield, without the added pressure of a global pandemic. Distinguishing between viral and bacterial infections can inform treatment decisions.
Improving breast cancer diagnosis with AI in pathology
Ibex Medical Analytics has announced a research partnership and joint study with Institut Curie, France’s leading cancer centre, for the first-ever blinded and independent evaluation of an AI solution for breast cancer detection.
Biomarker training programme launched
Agilent Technologies has launched the Biomarker Pathologist Training Programme, a global initiative created to empower pathologists to score biomarkers accurately and confidently.
Blood test offers diagnostic potential for HPV-related cancers
A potential breakthrough in the early detection of the neck, head and anal cancers linked to human papillomavirus (HPV) has emerged, based on a highly specific point-of-care blood test that appears to indicate cancer, and predict its course.
Galleri cancer test: comment from BIVDA
The Galleri blood test, developed by GRAIL, can detect early-stage cancers through a simple blood test, and will be piloted with 165,000 patients in a world-first deal struck by NHS England.
One Health: current and future challenges
Although John Cooper originally trained in veterinary science, he has always enjoyed working with those from other disciplines. Here, he puts the case for One Health and how this approach could be beneficial when facing new challenges in the future.
Stackable chilling incubators: applications in the life sciences
Torrey Pines Scientific has announced it new EchoTherm Stackable/Programmable Vibration-Free Chilling Incubators for protein crystallography and other life science uses.
Annual SHOT Report 2019: FAHR highlights webinar
The SHOT team will host its final webinar of 2020 on 2 December at 14:00 GMT, covering the Febrile, Allergic and Hypotensive Reactions (FAHR) chapter of the Annual SHOT Report 2019, along with a seven-year trend analysis.
Featured Supplier
Stago’s objective is to improve the health of as many people as possible by offering powerful biotechnology solutions for blood-based diagnostics.
We take a lean, confidence-building approach to digital connectivity – from our latest Coag.One middleware to our cyber-secure Connect.One capability for enhanced engineering and remote...
Upcoming Events
Lab Innovations 2021
NEC, Birmingham
3-4 November 2021
IBMS Biomedical Science Congress 2022
International Convention Centre, Birmingham
14-17 March 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
